Song Cheol Kim Selected Research

Neoplasms (Cancer)

3/2024	Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer.
11/2023	Evaluation of postoperative outcomes of minimally invasive distal pancreatectomy for left-sided pancreatic tumors based on the modified frailty index: a retrospective cohort study.
10/2023	A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma.
9/2023	High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
1/2023	Multi-biomarker panel prediction model for diagnosis of pancreatic cancer.
1/2023	Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6.
1/2023	Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study.
1/2023	Minimally invasive versus open pancreaticoduodenectomy for distal bile duct cancer: an inverse probability of treatment weighting analysis of outcomes.
11/2022	An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
11/2022	Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Song Cheol Kim Research Topics

Disease

80	Neoplasms (Cancer) 03/2024 - 02/2008
49	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 10/2011
42	Adenocarcinoma 02/2024 - 10/2011
11	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024 - 01/2015
10	Pancreatic Fistula (Pancreatic Fistulas) 01/2024 - 02/2015
8	Margins of Excision 05/2023 - 02/2015
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
6	Head and Neck Neoplasms (Head and Neck Cancer) 07/2023 - 06/2012
5	Primitive Neuroectodermal Tumors (PNET) 11/2021 - 02/2016
5	Carcinoma (Carcinomatosis) 04/2021 - 05/2018
5	Lymphatic Metastasis 10/2018 - 05/2015
4	Diabetes Mellitus 01/2020 - 06/2010
4	Pathologic Constriction (Stenosis) 01/2020 - 05/2014
3	Cysts 12/2023 - 01/2009
3	Gallbladder Neoplasms (Gallbladder Cancer) 05/2022 - 12/2014
3	Autoimmune Diseases (Autoimmune Disease) 08/2009 - 06/2008
2	Disease Progression 02/2024 - 05/2018
2	Hypoxia (Hypoxemia) 10/2022 - 05/2018
2	Klatskin Tumor 03/2021 - 09/2020
2	Pancreatitis 03/2021 - 11/2018
2	Weight Gain 01/2021 - 01/2020
2	Hemorrhage 12/2020 - 11/2018
2	Pain (Aches) 07/2020 - 07/2015
2	Type 2 Diabetes Mellitus (MODY) 06/2020 - 01/2020
2	Acute Cholecystitis 06/2020 - 01/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2020 - 10/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019 - 01/2019
2	Cholangitis 11/2018 - 11/2016
2	Carcinogenesis 07/2017 - 01/2016
2	Inflammation (Inflammations) 10/2016 - 09/2008
1	Choledochal Cyst (Choledochal Cysts) 12/2023
1	Frailty 11/2023
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2023
1	Neoplasms, Cystic, Mucinous, and Serous 01/2023
1	Fibrosis (Cirrhosis) 10/2022
1	Fatty Liver 08/2022

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
10	folfirinoxIBA 02/2024 - 07/2017
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
8	Gemcitabine FDA Link 10/2022 - 11/2012
7	AntigensIBA 10/2023 - 08/2009
5	CollagenIBA 11/2022 - 09/2016
4	CarbohydratesIBA 11/2021 - 08/2011
4	Insulin (Novolin)FDA Link 01/2021 - 06/2010
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2022
3	Fluorouracil (Carac)FDA LinkGeneric 05/2022 - 01/2016
2	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2021
2	N-acetyltalosaminuronic acid (NAT)IBA 03/2024 - 09/2022
2	Circulating Tumor DNAIBA 10/2023 - 01/2017
2	EnzymesIBA 01/2023 - 08/2022
2	Chimeric Antigen ReceptorsIBA 01/2023 - 10/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 01/2017
2	Capecitabine (Xeloda)FDA Link 01/2022 - 11/2012
2	HydrogelsIBA 12/2021 - 01/2020
2	Cell-Free Nucleic AcidsIBA 11/2021 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2021
2	Therapeutic UsesIBA 10/2021 - 01/2021
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 03/2021 - 05/2020
2	Peptides (Polypeptides)IBA 01/2021 - 07/2017
2	Hormones (Hormone)IBA 01/2021 - 05/2015
2	Neutralizing AntibodiesIBA 01/2021 - 01/2016
2	LigandsIBA 10/2020 - 09/2016
2	Thrombin FDA Link 09/2020 - 12/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2015
2	FibrinIBA 12/2019 - 06/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2019 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 04/2019 - 01/2019
2	Sunitinib (Sutent)FDA Link 01/2017 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 01/2009
1	Circular RNAIBA 10/2023
1	ImmunosorbentsIBA 01/2023
1	dibenzyldithiocarbamate (DBDC)IBA 01/2023
1	nintedanibIBA 01/2023
1	MesothelinIBA 01/2023
1	glycol-chitosanIBA 11/2022
1	Hyaluronic Acid (Hyaluronan)IBA 11/2022
1	N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA 08/2022

Therapy/Procedure

30	Pancreaticoduodenectomy 01/2024 - 02/2008
25	Pancreatectomy 11/2023 - 02/2008
14	Therapeutics 02/2024 - 06/2012
13	Adjuvant Chemotherapy 07/2023 - 11/2014
12	Neoadjuvant Therapy 03/2024 - 06/2012
11	Drug Therapy (Chemotherapy) 10/2022 - 01/2009
9	Length of Stay 05/2022 - 02/2015
8	Stents 10/2021 - 05/2014
5	Operative Surgical Procedures 01/2019 - 06/2012
4	Pancreaticojejunostomy 07/2020 - 08/2019
3	Minimally Invasive Surgical Procedures 12/2023 - 07/2021
3	Operative Time 04/2023 - 02/2015
3	Cholecystectomy 05/2022 - 12/2014
3	Radiotherapy 01/2019 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 07/2021
2	Laparoscopic Cholecystectomy 06/2020 - 01/2017
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 11/2012
2	Transplantation 12/2019 - 06/2008
2	Self Expandable Metallic Stents 11/2016 - 11/2016
2	Aftercare (After-Treatment) 11/2016 - 01/2009
2	Organ Transplantation 08/2009 - 09/2008
1	Splenectomy 08/2022